Novartis

North Chicago, Illinois 60064

0 studies enrolling now · 1 studies all time

What they study most

Hyperphosphatemia Patients With Chronic Kidney Disease on 3x/Week Replacement Therapy

Studies at this site

• Efficacy of SBR759 in Lowering Serum Phosphate Levels in Chronic Kidney Disease Patients on Hemodialysis — Completed